BJL
RXST icon

Brighton Jones LLC’s RxSight RXST Stock Holding History

Brighton Jones LLC’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.1K Buy
+12,051
New +$72.7K ﹤0.01% 1359

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Brighton Jones LLC's RXST Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in RxSight (RXST) in Q2 2026: 12,051 shares worth $58.1K. The stake represents ﹤0.01% of the portfolio and ranks #1359 among its holdings.

58 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Brighton Jones LLC held 12,051 shares of RxSight worth $58.1K as of Q2 2026.
  • RxSight was a new Brighton Jones LLC position in Q2 2026.
  • RxSight made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1359 holding.
  • 58 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.